Search results for "Rodin"

Disoleatori statici per il trattamento delle acque di piccole e medie utenze

2012

Per rimuovere gli olii dalle acque reflue di piccole e medie utenze si utilizzano molto i disoleatori prefabbricati. Le verifiche di tre disoleatori commerciali di tipo statico hanno suggerito il limite inferiore per il tempo di detenzione idraulica, e quello superiore per il carico superficiale. Le vasche bi-stadio non hanno dimostrato vantaggi sulle mono-stadio.

Demo 6. Caída de cuerpos en ausencia de aire

2013

Objetivo: Demostrar que, en ausencia de aire (vacío parcial de aire), el tiempo de caída de los cuerpos es independiente de su masa o forma.

The most ancient ophiolite of the Central Asian fold belt: U–Pb and Pb–Pb zircon ages for the Dunzhugur Complex, Eastern Sayan, Siberia, and geodynam…

2002

Abstract Ophiolitic rocks with a zircon age of ∼1020 Ma occur in the Dunzhugur complex of East Sayan, Siberia, and are part of a Neoproterozoic to early Palaeozoic segment of the Central Asian fold belt. The most spectacular suite is exposed along the Oka and Bokson rivers, where a complete ophiolite sequence with mantle tectonites, a layered sequence composed of dunite, wehrlite, and pyroxenite, a gabbro section, a sheeted diabase dyke complex and basaltic pillow lavas are exposed. Petrologic and geochemical data suggest that all members of the ophiolite originally belonged to the same cogenetic mafic–ultramafic crustal section and support a supra-subduction zone setting in a fore-arc rift…

Homogēnu un heterogēnu reakciju modelēšana gazifikācijas procesā

2020

Ik gadu pieaugošais pieprasījums pēc enerģijas, kas saistīts ar pasaules populācijas pieaugšanu un nepārtrauktu industralizāciju, liek meklēt veidus, kā enerģiju iegūt pēc iespējas videi draudzīgākā ceļā. Tiek paredzēts, ka gazifikācija kā enerģijas iegūšanas veids nākotnē kļūs aizvien pieprasītāks, jo kā izejmateriālu iespējams izmantot dažāda veida biomasas, tai skaitā jebkādus organiskos atkritumus, kas ļauj izvairīties no neataunojamo dabas resursu patērēšanas. Lai arī gazifikācija ir jau sen pazīstams enerģijas iegūšanas veids, tā kontrole ir sarežģīta un procesa efektivitāte nav bijusi pietiekama, kas ir kavējis plašāku tās izmantošanu. Lai šo procesu labāk izprastu un optimizētu, pēd…

Comportamento idrodinamico dei letti fluidizzati e stima della porosità

2007

Analytical solutions of magnetohydrodynamical problems on a flow of conducting fluid in the entrance region of channels in a strong magnetic field šķ…

2014

Darbā iegūti analītiskie atrisinājumi magnetohidrodinamiskiem (MHD) uzdevumiem par elektrovadoša šķidruma plūsmu plakanā un cilindriskā kanālā stiprā magnētiskā laukā gadījumiem, kad šķidrums ietek kanālos caur galīga platuma spraugu vai caur galīga rādiusa atveri kanāla sānu malā. Pamatojoties uz iegūtajiem atrisinājumiem, veikta plūsmas ātruma lauka skaitliskā analīze. Iegūti uzdevumu asimptotiskie atrisinājumi lieliem Hartmana skaitļiem. Turklāt darbā pētīta pilna spiediena spēka šķidruma ieplūdes apgabalā atkarība no funkcijas veida, ar kuru ir uzdots ātruma robežnosacījums. Pētījums veikts analītiski, risinot divas hidrodinamiskas problēmas un divas MHD problēmas par viskoza šķidruma i…

New strategies for medical management of overactive bladder in children.

2011

Purpose of review The medical treatment of children with non-neurogenic overactive bladder syndrome (OAB) is still limited to a small number of drugs approved for use in childhood according to the national regulations of each country. Recent findings Over the last few years, there were several studies on the use of antimuscarinics other than oxybutynin in children, as well as some on the use of extended release oxybutynin and tolterodine and transdermal oxybutynin. It was shown that the combination of two different anticholinergics might be a well tolerated and successful option in children with OAB refractory to monotherapy, as well as administration of a receptor-selective antimuscarinic …

Safety and tolerability of β3-adrenoceptor agonists in the treatment of overactive bladder syndrome - insight from transcriptosome and experimental s…

2016

We have reviewed the safety and tolerability of β3-adrenoceptor agonists, specifically mirabegron and solabegron, a newly emerging drug class for the treatment of the overactive bladder syndrome. We discuss them mechanistically in the context of expression and other preclinical data.Based on a systematic PubMed search, incidence of overall adverse events, hypertension, dry mouth, and constipation are comparable between mirabegron or solabegron and placebo. Hypertension is the most frequently observed adverse event, but has a similar incidence with mirabegron and placebo. Nevertheless, severe uncontrolled hypertension has become a contraindication for use of mirabegron based on observation o…

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

2013

Aims Mirabegron, the first β3-adrenoceptor agonist to enter clinical practice, has a different mechanism of action from antimuscarinic agents. This review presents data on the efficacy, safety, and tolerability of mirabegron in studies conducted to date. Methods All clinical data on mirabegron that are currently in the public domain are included, including some in-press manuscripts. Results In Phase III clinical trials in patients with overactive bladder (OAB), mirabegron at daily doses of 25, 50, and 100 mg demonstrated significant efficacy in treating the symptoms of OAB, including micturition frequency, urgency incontinence, and urgency. Significant improvements in micturition frequency,…

Long-term safety, tolerability and efficacy of flexible-dose fesoterodine in elderly patients with overactive bladder: Open-label extension of the SO…

2013

Aims To assess the long-term safety, tolerability, and efficacy of flexible-dose fesoterodine in elderly patients with OAB. Methods Patients aged ≥65 years who completed a 12-week, randomized, double-blind, placebo-controlled trial were eligible for the 12-week, open-label (OL) extension phase. Patients who received double-blind placebo started on fesoterodine 4 mg and could increase to 8 mg after 4 or 8 weeks of OL treatment, while fesoterodine-treated patients continued on their double-blind dose; only one dose escalation or de-escalation was permitted. Discontinuations and adverse events (AEs) were monitored, and patients completed 3-day bladder diaries and patient-reported outcomes at t…